Pre-warmed Intravenous Fluids and Monitored Anesthesia Care
Study Details
Study Description
Brief Summary
The aim of the study is to compare effect of pre-warmed intravenous fluids on the early outcomes in ambulatory patients undergoing monitored anesthesia care.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
N/A |
Detailed Description
Monitored anesthesia care (MAC) has been increasing in fast track anesthesia for ambulatory or outpatient surgery. MAC provides lower anesthetic agents than general anesthesia, however it has been shown to result high anesthetic complication rate because of negligent monitoring. Therefore, aim of this study is to investigate the effect of pre-warmed intravenous fluids on the core body temperature and the early outcomes.
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Experimental: Pre-warmed fluids Pre-warmed fluids will be prepared for 8hous in 41℃ set hot cabinet. |
Other: Pre-warmed fluids
IV fluid will be stored at 41℃ set hot cabinet for 8hours
Other Names:
|
Experimental: Room temperature fluids Room temperature fluids will be stored at ambient temperature. |
Other: Room temperature fluids
Room temperature fluid will be stored at ambient temperature
Other Names:
|
Outcome Measures
Primary Outcome Measures
- Tympanic membrane temperature [30min after anesthetic induction]
Preoperative dehydration will be supplemented with 10ml/kg of lactate Ringer's solution at the beginning of the anesthetic induction. 30 min after anesthetic induction is nearly after administering the fixed volume.
Secondary Outcome Measures
- Postoperative chilling and shivering [on arrival at the postanesthetic care unit ( 1hour after the anesthetic induction)]
Degree of chilling and shivering will be evaluated at the postanesthesia care unit after the surgery.
Eligibility Criteria
Criteria
Inclusion Criteria:
- 20years to 70years old female patients undergoing urinary incontinence surgery under monitored anesthesia care.
Exclusion Criteria:
-
Preoperative tympanic membrane temperature >38 or < 36
-
End stage heart failure or renal failure
-
Otitis media
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Samsung medical center | Seoul | Korea, Republic of | 135-710 |
Sponsors and Collaborators
- Samsung Medical Center
Investigators
- Principal Investigator: Myung Hee Kim, MD,PhD, Samsung MC
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- Prewarmed fluid